leukoencephalopathy

• “A Biogen spokeswoman said the company worked with the Food and Drug Administration on the change, which includes a table that details the incidence of progressive multifocal leukoencephalopathy, or PML.”

  The Wall Street Journal: Biogen, Elan's Tysabri Label Updated

• “Its joint venture partner on Tysabri, U. S.-based Biogen Idec, suspended Tysabri in the U.S. in 2005 after two patients using combination therapy contracted a rare brain infection, progressive multifocal leukoencephalopathy or PML.”

  The Wall Street Journal: Drug Maker Elan Swings to Loss

• “Some patients taking the drug developed a rare infection—progressive multifocal leukoencephalopathy, or PML—and two patients died.”

  Simon & Schuster: The Autoimmune Epidemic

• “Elan and its joint venture partner on Tysabri, U. S.-based Biogen Idec Inc., suspended Tysabri in the U.S. in 2005 after two patients using combination therapy contracted a rare brain infection, progressive multifocal leukoencephalopathy or PML.”

  The Wall Street Journal: Drug Maker Elan Narrows Loss

• “Elan and Biogen suspended Tysabri in the U.S. in 2005 after two MS patients using combination therapy contracted a rare brain infection, progressive multifocal leukoencephalopathy or PML.”

  The Wall Street Journal: Elan Considers EDT Spinoff

• “But the agency said it was concerned with two serious side effects seen in clinical studies, one being post-transplant lymphoproliferative disorder — a type of lymphoma associated with organ-transplant patients — and a brain infection known as progressive multifocal leukoencephalopathy, or PML, that was seen in one patient in the kidney studies and another patient in an ongoing liver-transplant study.”

  The Wall Street Journal: Drug to Help Transplants Wins Support

• “Four confirmed or suspected cases of the infection, called progressive multifocal leukoencephalopathy (PML), have been linked to the drug since it was approved for adults with moderate to severe chronic  psoriasis in 2003.”

  Consumer Reports: FDA issues advisory for psoriasis drug Raptiva

• “Now comes word that Genentech is voluntarily recalling the drug because of the risk of the rare brain infection called progressive multifocal leukoencephalopathy (PML).”

  Consumer Reports: Psoriasis drug Raptiva recalled

• “Now comes word that Genentech is voluntarily recalling the drug because of the risk of the rare brain infection called progressive multifocal leukoencephalopathy PML.”

  Consumer Reports: Psoriasis drug Raptiva recalled

• “Four confirmed or suspected cases of the infection, called progressive multifocal leukoencephalopathy PML, have been linked to the drug since it was approved for adults with moderate to severe chronic psoriasis in 2003.”

  Consumer Reports: FDA issues advisory for psoriasis drug Raptiva

Show 10 more examples...